DK3929303T3 - Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastro-entero-pankreatisk neuroendokrint neoplasma - Google Patents

Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastro-entero-pankreatisk neuroendokrint neoplasma Download PDF

Info

Publication number
DK3929303T3
DK3929303T3 DK21169154.8T DK21169154T DK3929303T3 DK 3929303 T3 DK3929303 T3 DK 3929303T3 DK 21169154 T DK21169154 T DK 21169154T DK 3929303 T3 DK3929303 T3 DK 3929303T3
Authority
DK
Denmark
Prior art keywords
neoplasma
entero
gastro
diagnosing
kits
Prior art date
Application number
DK21169154.8T
Other languages
Danish (da)
English (en)
Inventor
Irvin Mark Modlin
Mark Kidd
Ignat Drozdov
Original Assignee
Clifton Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clifton Life Sciences LLC filed Critical Clifton Life Sciences LLC
Application granted granted Critical
Publication of DK3929303T3 publication Critical patent/DK3929303T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK21169154.8T 2014-09-15 2015-09-15 Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastro-entero-pankreatisk neuroendokrint neoplasma DK3929303T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462050465P 2014-09-15 2014-09-15
EP15771837.0A EP3194618B1 (en) 2014-09-15 2015-09-15 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Publications (1)

Publication Number Publication Date
DK3929303T3 true DK3929303T3 (da) 2025-03-03

Family

ID=54207775

Family Applications (2)

Application Number Title Priority Date Filing Date
DK21169154.8T DK3929303T3 (da) 2014-09-15 2015-09-15 Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastro-entero-pankreatisk neuroendokrint neoplasma
DK15771837.0T DK3194618T3 (da) 2014-09-15 2015-09-15 Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastroenteropankreatisk neuroendokrin neoplasma

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK15771837.0T DK3194618T3 (da) 2014-09-15 2015-09-15 Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastroenteropankreatisk neuroendokrin neoplasma

Country Status (13)

Country Link
US (4) US10407730B2 (cg-RX-API-DMAC7.html)
EP (2) EP3194618B1 (cg-RX-API-DMAC7.html)
JP (2) JP6782700B2 (cg-RX-API-DMAC7.html)
KR (2) KR102762958B1 (cg-RX-API-DMAC7.html)
CN (1) CN107208132A (cg-RX-API-DMAC7.html)
AU (3) AU2015317893B2 (cg-RX-API-DMAC7.html)
CA (1) CA2959670C (cg-RX-API-DMAC7.html)
DK (2) DK3929303T3 (cg-RX-API-DMAC7.html)
ES (2) ES3013599T3 (cg-RX-API-DMAC7.html)
IL (2) IL250867B (cg-RX-API-DMAC7.html)
MX (2) MX386919B (cg-RX-API-DMAC7.html)
PL (2) PL3194618T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016044330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10407730B2 (en) 2014-09-15 2019-09-10 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
MX2019014026A (es) * 2017-05-25 2020-08-03 Liquid Biopsy Res Llc Metodos para la deteccion de melanoma.
CN118910259A (zh) * 2017-11-30 2024-11-08 液体活检研究有限责任公司 使用基因表达测定预测肽受体放射治疗
CN108048564B (zh) * 2018-02-09 2021-03-05 中国科学院昆明动物研究所 人glt8d1基因的新用途
US11948296B2 (en) * 2018-07-30 2024-04-02 Agency For Science, Technology And Research Method and system for assessing fibrosis in a tissue sample
EP4041886A1 (en) 2019-10-10 2022-08-17 Liquid Biopsy Research LLC Compositions, methods and kits for biological sample and rna stabilization
FR3110764B1 (fr) 2020-05-20 2024-05-10 Quantum Surgical Méthode de prédiction de la récidive d’une lésion par analyse d’images
CN113215255B (zh) * 2021-04-26 2022-04-05 山东天川精准医疗科技有限公司 用于肝癌早期诊断或预后的生物标记物及其用途
CN120153081A (zh) * 2022-07-15 2025-06-13 埃门多生物公司 Aplp2安全港位点敲入策略
CN120380169A (zh) * 2022-09-30 2025-07-25 液体活检研究有限责任公司 用于在唾液中检测神经内分泌癌的方法
CN117292755B (zh) * 2023-08-09 2026-02-06 郑州大学 多模态临界边生物标志物识别方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084883A1 (en) 2003-08-25 2005-04-21 The Johns Hopkins University School Of Medicine Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
JP5728380B2 (ja) * 2008-06-12 2015-06-03 シンタクシン リミテッドSyntaxin Limited 神経内分泌疾患の抑制
AU2012223288B2 (en) 2011-03-01 2017-03-30 Yale University Predicting gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
US10407730B2 (en) 2014-09-15 2019-09-10 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Also Published As

Publication number Publication date
AU2015317893A1 (en) 2017-03-23
US20260043085A1 (en) 2026-02-12
JP7157788B2 (ja) 2022-10-20
KR20170045365A (ko) 2017-04-26
IL281355B (en) 2022-02-01
JP2021019618A (ja) 2021-02-18
IL281355A (en) 2021-04-29
KR20250021631A (ko) 2025-02-13
US20220325351A1 (en) 2022-10-13
AU2021212151A1 (en) 2021-08-26
MX386919B (es) 2025-03-19
PL3194618T3 (pl) 2021-12-13
BR112017005279A2 (pt) 2017-12-12
CA2959670A1 (en) 2016-03-24
AU2023258444A1 (en) 2023-11-23
MX2017003370A (es) 2017-11-22
US10407730B2 (en) 2019-09-10
EP3194618A1 (en) 2017-07-26
US11168372B2 (en) 2021-11-09
US20190345568A1 (en) 2019-11-14
AU2015317893B2 (en) 2021-05-20
AU2021212151B2 (en) 2023-08-03
EP3929303A1 (en) 2021-12-29
CA2959670C (en) 2024-02-20
JP6782700B2 (ja) 2020-11-11
CN107208132A (zh) 2017-09-26
PL3929303T3 (pl) 2025-04-28
US12258633B2 (en) 2025-03-25
EP3194618B1 (en) 2021-04-21
MX2021012347A (es) 2021-10-22
IL250867A0 (en) 2017-04-30
JP2017528164A (ja) 2017-09-28
DK3194618T3 (da) 2021-07-12
WO2016044330A1 (en) 2016-03-24
EP3929303B1 (en) 2024-12-04
ES3013599T3 (en) 2025-04-14
KR102762958B1 (ko) 2025-02-04
IL250867B (en) 2021-03-25
ES2881474T3 (es) 2021-11-29
US20160076106A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
DK3940352T3 (da) Fremgangsmåde til diagnosticering af vægte
DK3161124T3 (da) Endofytter, associerede sammensætninger og fremgangsmåder til anvendelse deraf
DK3247371T3 (da) Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil
DK3194618T3 (da) Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastroenteropankreatisk neuroendokrin neoplasma
DK3259386T3 (da) Systemer og fremgangsmåder til udførelse af immunoassays
DK3430750T3 (da) Fremgangsmåde til delvis retransmission
BR112017004334A2 (pt) inibidores de desmetilase específica de lisina-1.
DK3245225T3 (da) Sammensætninger og fremgangsmåder til behandling og detektering af cancere
DK3359281T3 (da) Fremgangsmåde til udtrækning af CO2
GB2524479B (en) Testing rig
DK3198026T3 (da) Fremgangsmåde til bestemmelse af pik3ca-mutationsstatus i en prøve
DK3148725T3 (da) Fremgangsmåde til fremstilling af en langstrakt metalflaske med lav spredning
HUE055913T2 (hu) Módszerek és készítmények a glioblastoma diagnosztizálására és kezelésére
DK3314010T3 (da) Fremgangsmåde til detektering af kromosomaberrationer
DK3113675T3 (da) Fremgangsmåde til overførsel af point-of-care-testdata
EP3312612A4 (en) AUTOMATED ANALYZER
DK3350408T3 (da) Rørformet borehulsfræseindretning, navnlig egnet til indsættelse af snoet rørledning
FI20146115A7 (fi) Menetelmä kemikaalitestausta varten
EP3511720A4 (en) Automatic analyzer
DK3204492T3 (da) Fremgangsmåde til generering af t-celleforløbere
DK3520591T3 (da) Fremgangsmåde til spredning af gødningsmidler
DK3367910T3 (da) Fremgangsmåde til anvendelse af en sondeafdækning
IL254783A0 (en) Anthelmintic combinations and methods of use thereof
DK3177785T3 (da) Hjælpemonteringsværktøj til placering af elementer og anvendelse af nævnte værktøj
EP3330716A4 (en) AUTOMATED ANALYZER